A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 30, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the filing for Q3 FY2025, filed Aug 15, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BINI SEC filings page.
Bollinger Innovations New (BINI) reported $9.3M in revenue over the twelve months to Jun 30, 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
The business remains development-stage: small revenue sits beside very large operating spending and a liability-heavy balance sheet.
FY2024 revenue was$1.1M , up from$366K in FY2023, but revenue expansion did not translate into self-financing operations. Operating cash flow was-$185.6M while current liabilities were$183.2M , putting cash generation and near-term claims on nearly the same scale.
FY2024 R&D spending was
FY2024 current assets were
Financial Health Signals
We do not publish a peer-relative financial health score for Bollinger Innovations New, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Bollinger Innovations New scores -26.22, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $2.3B against total assets of $178.6M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Bollinger Innovations New passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.
Bollinger Innovations New reported a net loss of $457.1M while operations used $185.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Bollinger Innovations New reported an operating loss of $391.8M against $1.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Bollinger Innovations New generated $474K in revenue in Q3 2025. This represents an increase of 626.1% from the same quarter a year earlier. Against the prior quarter it is down 90.4%.
Bollinger Innovations New's EBITDA was -$55.1M in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Bollinger Innovations New reported a net loss of $129.7M in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2025.
Cash & Balance Sheet
Bollinger Innovations New recorded an outflow of $21.2M in free cash flow in Q3 2025, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Bollinger Innovations New held $455K in cash as of Q3 2025; no long-term debt figure is on record for that period.
Not reported for Q3 2025.
Margins & Returns
Not shown for Q3 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q3 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q3 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q3 2025.
Capital Allocation
Bollinger Innovations New invested $11.6M in research and development in Q3 2025. This represents a decrease of 18.9% from the same quarter a year earlier. Against the prior quarter it is up 11.8%.
Bollinger Innovations New invested $379K in capex in Q3 2025, funding long-term assets and infrastructure. This represents a decrease of 76.1% from the same quarter a year earlier. Against the prior quarter it is down 76.9%.
Not reported for Q3 2025.
BINI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Revenue | $474K+626.1% | $5.0M+14749.7% | $2.9Mn/m | $996K | $65K-78.8% | $33Kn/m | $0 | N/A |
| Cost of Revenue | $10.6M+29243.5% | $7.0M+51960.5% | $6.6M | N/A | $36K-85.5% | $13Kn/m | N/A | N/A |
| Gross Profit | -$10.1M-34630.8% | -$2.0M-10388.0% | -$3.7M | N/A | $29K-50.7% | $20Kn/m | N/A | N/A |
| R&D Expenses | $11.6M-18.9% | $10.4M-56.9% | $11.3M-30.2% | $20.4M-22.1% | $14.3M-35.3% | $24.0M+17.3% | $16.2M+87.5% | $26.2M+118.6% |
| SG&A Expenses | $36.2M-23.8% | $41.4M-13.6% | $36.5M-15.6% | $43.3M-39.5% | $47.5M+49.4% | $47.9M+1.0% | $43.2M-33.5% | $71.7M+221.8% |
| Operating Income | -$58.2Mn/m | -$65.8Mn/m | -$51.4Mn/m | -$93.3Mn/m | -$61.8Mn/m | -$177.4Mn/m | -$59.4Mn/m | -$182.5Mn/m |
| EBITDA | -$55.1Mn/m | -$61.0Mn/m | -$46.7Mn/m | N/A | -$58.3Mn/m | -$167.4Mn/m | -$55.1Mn/m | N/A |
| Interest Expense | $25.7M+210.0% | $1.2M+500.0% | $900K+800.0% | N/A | $8.3M+1260.7% | $200K-89.4% | $100K | N/A |
| Income Tax | $600-50.0% | $600n/m | $600n/m | $1K | $1K-99.7% | -$2.2Mn/m | -$1.7M | N/A |
| Net Income | -$129.7Mn/m | -$47.1Mn/m | -$114.9Mn/m | -$175.9Mn/m | -$87.4Mn/m | -$132.4Mn/m | -$61.4Mn/m | -$172.2Mn/m |
| EPS (Basic) | -$11231.39 | -$489.24n/m | -$661.33 | N/A | -$1000000.00 | -$12.04 | -$91940.42 | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | -$7.91 | N/A | -$15.32 | N/A |
| Diluted Shares (Avg) | N/A | N/A | N/A | N/A | 12M | N/A | 4M | N/A |
BINI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $89.2M-53.6% | $150.1M-29.9% | $173.0M-54.6% | $178.6M-57.6% | $192.3M-65.7% | $214.1M-46.8% | $381.2M-13.6% | $421.7M+39.4% |
| Current Assets | $42.4M-37.3% | $52.9M-40.5% | $59.9M-58.3% | $63.2M-68.1% | $67.6M-73.5% | $88.9M-10.2% | $143.5M+5.9% | $198.1M+129.5% |
| Cash & Equivalents | $455K-87.2% | $1.4M-93.7% | $2.3M-97.1% | $10.3M-93.4% | $3.5M-98.3% | $22.4M-62.9% | $81.5M+19.7% | $155.3M+187.1% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $28.1M-25.6% | $38.3M+16.1% | $41.8M+36.0% | $37.5M+123.1% | $37.8M+211.5% | $33.0M+373.7% | $30.7M+341.5% | $16.8M |
| Accounts Receivable | $0n/m | $0n/m | $99K | $124K-81.5% | $0-100.0% | $0 | N/A | $672K |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $0n/m | $0n/m | N/A | $0-100.0% | $0-100.0% | $0-100.0% | $28.8M-68.9% | $28.8M-68.9% |
| Total Liabilities | $196.3M+40.9% | $219.6M+127.1% | $267.2M+144.3% | $195.2M+31.1% | $139.3M-33.1% | $96.7M-58.6% | $109.4M-78.8% | $148.9M-39.0% |
| Current Liabilities | $186.5M+47.3% | $209.0M+150.1% | $246.1M+155.2% | $183.2M+31.2% | $126.6M-33.4% | $83.5M-31.2% | $96.4M-75.7% | $139.6M+14.2% |
| Non-Current Liabilities | $9.8M-23.3% | $10.7M-19.0% | $21.1M+63.4% | $12.0M+29.3% | $12.8M-29.6% | $13.2M-88.3% | $12.9M-89.1% | $9.3M-92.4% |
| Long-Term Debt | N/A | N/A | $13.2M+73.4% | $0n/m | $0-100.0% | $0-100.0% | $7.6M+55.9% | $0-100.0% |
| Total Equity | -$107.9M-408.9% | -$73.0M-176.7% | -$103.1M-149.0% | -$28.6M-113.7% | $34.9M-86.6% | $95.1M-43.8% | $210.6Mn/m | $209.0M+256.0% |
| Retained Earnings | -$2.6Bn/m | -$2.5Bn/m | -$2.4Bn/m | -$2.3Bn/m | -$2.1Bn/m | -$2.1Bn/m | -$1.9Bn/m | -$1.9Bn/m |
BINI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$20.8Mn/m | -$23.0Mn/m | -$25.6Mn/m | -$40.4Mn/m | -$36.7Mn/m | -$48.6Mn/m | -$59.9Mn/m | -$65.5Mn/m |
| Depreciation & Amortization | $3.0M-12.3% | $4.8M-52.1% | $4.7M+9.3% | $4.2M-21.9% | $3.5M+40.1% | $10.0M+167.2% | $4.3M-9.4% | $5.4M+128.4% |
| Stock-Based Compensation | $24.7M+82.4% | $23.7M+1288.2% | $18.6M+33.7% | N/A | $13.6M+26.6% | $1.7M-91.3% | $13.9M-65.9% | N/A |
| Capital Expenditures | $379K-76.1% | $1.6M-70.7% | $2.2M-67.7% | $694K+286.2% | $1.6M-84.2% | $5.6M+56.9% | $6.9M+845.1% | $180K-71.8% |
| Free Cash Flow | -$21.2Mn/m | -$24.7Mn/m | -$27.8Mn/m | -$41.1Mn/m | -$38.3Mn/m | -$54.2Mn/m | -$66.8Mn/m | -$65.7Mn/m |
| Investing Cash Flow | -$379Kn/m | -$1.6Mn/m | -$2.2Mn/m | -$2.1Mn/m | -$1.6Mn/m | -$5.6Mn/m | -$6.9Mn/m | -$474Kn/m |
| Financing Cash Flow | $19.7M+58.5% | $24.2Mn/m | $19.8Mn/m | $49.3Mn/m | $12.4M-93.7% | -$4.9M-128.5% | $0-100.0% | -$5.7M-107.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
BINI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -2130.6% | -41.3%-101.0pp | -125.6% | N/A | 44.8%+25.5pp | 59.7% | N/A | N/A |
| Operating Margin | -12282.3% | -1329.0% | -1761.2% | -9368.1% | -94689.9% | -532079.9% | N/A | N/A |
| Net Margin | -27386.2% | -951.0% | -3933.9% | -17662.2% | -133917.1% | -397276.0% | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | -250.1%-131.4pp | -139.3%-71.3pp | -29.2% | -82.4%+350.3pp |
| Return on Assets | -145.4%-100.0pp | -31.4%+30.5pp | -66.4%-50.3pp | -98.5%-57.6pp | -45.4%+9.7pp | -61.9%-33.3pp | -16.1%+69.2pp | -40.8%+43.1pp |
| Current Ratio | 0.23-0.3x | 0.25-0.8x | 0.24-1.2x | 0.34-1.1x | 0.53-0.8x | 1.06+0.2x | 1.49+1.1x | 1.42+0.7x |
| Debt-to-Equity | N/A | N/A | N/A | N/A | 0.000.0x | 0.000.0x | 0.04 | 0.00-0.1x |
| Liabilities-to-Equity | N/A | N/A | N/A | N/A | 3.99+3.2x | 1.02-0.4x | 0.52 | 0.71-3.4x |
| Asset Turnover | 0.010.0x | 0.030.0x | 0.020.0x | 0.01 | 0.000.0x | 0.000.0x | 0.00 | N/A |
| FCF Margin | -4475.3% | -498.2% | -951.4% | -4124.2% | -58701.2% | -162549.1% | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$28.6M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.34), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Bollinger Innovations New BINI | FY2024 | $1.1M | -$457.1M | N/A | $25K | — |
| Thunder Power Holdings AIEV | FY2025 | N/A | -$2.1M | N/A | $13.3M | — |
| Damon Inc DMNIF | FY2025 | $223K | -$5.4M | N/A | $1.2M | — |
| Phoenix Motor Inc PEVM | FY2024 | $31.2M | $7.9M | 25.5% | $1K | — |
Where Bollinger Innovations New Ranks
Frequently Asked Questions
Bollinger Innovations New (BINI) reported $1.1M in total revenue for fiscal year 2024. This represents a 199.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Bollinger Innovations New (BINI) revenue grew by 199.0% year-over-year, from $366K to $1.1M in fiscal year 2024.
No, Bollinger Innovations New (BINI) reported a net loss of $467.6M over the trailing 12 months to June 30, 2025. In fiscal year 2024 it reported a net loss of $457.1M.
Bollinger Innovations New (BINI) had EBITDA of -$369.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2024, Bollinger Innovations New (BINI) had $10.3M in cash and equivalents against $0 in long-term debt.
Bollinger Innovations New (BINI) recorded an outflow of $200.3M in free cash flow during fiscal year 2024. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Bollinger Innovations New (BINI) recorded an outflow of $185.6M in operating cash flow during fiscal year 2024, representing cash used by core business activities.
Bollinger Innovations New (BINI) had $178.6M in total assets as of fiscal year 2024, including both current and long-term assets.
Bollinger Innovations New (BINI) invested $14.7M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Bollinger Innovations New (BINI) invested $74.9M in research and development during fiscal year 2024.
Bollinger Innovations New (BINI) had a current ratio of 0.34 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
Bollinger Innovations New (BINI) had a return on assets of -255.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
Bollinger Innovations New (BINI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2025). The market capitalization is $25K as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Bollinger Innovations New (BINI) trades at 0.0x sales, its market capitalization divided by $9.3M revenue, trailing 12 months to June 30, 2025. The market capitalization is $25K as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2024, Bollinger Innovations New (BINI) held $10.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $185.6M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Bollinger Innovations New (BINI) has negative shareholder equity of -$28.6M as of fiscal year 2024, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Bollinger Innovations New (BINI) has an Altman Z-Score of -26.22, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Bollinger Innovations New (BINI) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Bollinger Innovations New (BINI) reported a net loss of $457.1M while operations used $185.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Bollinger Innovations New (BINI) reported an operating loss of $391.8M against $1.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.